HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicolas Bonne Selected Research

Therapeutics

10/2017The efficacy of lapatinib and nilotinib in combination with radiation therapy in a model of NF2 associated peripheral schwannoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicolas Bonne Research Topics

Disease

2Neurofibromatosis 2 (Neurofibromatosis Type II)
10/2017 - 08/2011
1Neoplasms (Cancer)
10/2017
1Neurilemmoma (Schwannoma)
10/2017
1Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)
10/2017
1Acoustic Neuroma (Acoustic Neurinoma)
08/2011

Drug/Important Bio-Agent (IBA)

1Bevacizumab (Avastin)FDA Link
10/2017
1EverolimusFDA Link
10/2017
1Lapatinib (GW572016)FDA Link
10/2017
1nilotinibFDA Link
10/2017

Therapy/Procedure

1Aftercare (After-Treatment)
10/2017
1Therapeutics
10/2017
1Radiotherapy
10/2017
1Decompression
08/2011